Moderna Shares Surge on Bird Flu Vaccine Hopes
Moderna shares rise as investors anticipate success in its experimental bird flu vaccine. Explore the potential impact on the biotech market.
Moderna shares rose on expectations for its experimental bird flu vaccine.